352 related articles for article (PubMed ID: 18690918)
21. The cost effectiveness of bisphosphonates for the prevention and treatment of osteoporosis: a structured review of the literature.
Fleurence RL; Iglesias CP; Johnson JM
Pharmacoeconomics; 2007; 25(11):913-33. PubMed ID: 17960951
[TBL] [Abstract][Full Text] [Related]
22. Effects of antifracture drugs in postmenopausal, male and glucocorticoid-induced osteoporosis--usefulness of alendronate and risedronate.
Iwamoto J; Takeda T; Sato Y
Expert Opin Pharmacother; 2007 Nov; 8(16):2743-56. PubMed ID: 17956196
[TBL] [Abstract][Full Text] [Related]
23. How to manage postmenopausal osteoporosis?
Body JJ
Acta Clin Belg; 2011; 66(6):443-7. PubMed ID: 22338309
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of Pharmacological Therapies for the Prevention of Fractures in Postmenopausal Women: A Network Meta-Analysis.
Barrionuevo P; Kapoor E; Asi N; Alahdab F; Mohammed K; Benkhadra K; Almasri J; Farah W; Sarigianni M; Muthusamy K; Al Nofal A; Haydour Q; Wang Z; Murad MH
J Clin Endocrinol Metab; 2019 May; 104(5):1623-1630. PubMed ID: 30907957
[TBL] [Abstract][Full Text] [Related]
25. Bisphosphonate treatment of osteoporosis.
Watts NB
Clin Geriatr Med; 2003 May; 19(2):395-414. PubMed ID: 12916293
[TBL] [Abstract][Full Text] [Related]
26. Vitamin K₂ therapy for postmenopausal osteoporosis.
Iwamoto J
Nutrients; 2014 May; 6(5):1971-80. PubMed ID: 24841104
[TBL] [Abstract][Full Text] [Related]
27. Indirect comparison of teriparatide, denosumab, and oral bisphosphonates for the prevention of vertebral and nonvertebral fractures in postmenopausal women with osteoporosis.
Zhang L; Pang Y; Shi Y; Xu M; Xu X; Zhang J; Ji L; Zhao D
Menopause; 2015 Sep; 22(9):1021-5. PubMed ID: 25944523
[TBL] [Abstract][Full Text] [Related]
28. Etidronate and alendronate in the treatment of postmenopausal osteoporosis.
Beauchesne MF; Miller PF
Ann Pharmacother; 1999 May; 33(5):587-99. PubMed ID: 10369624
[TBL] [Abstract][Full Text] [Related]
29. Response of serum carboxylated and undercarboxylated osteocalcin to alendronate monotherapy and combined therapy with vitamin K2 in postmenopausal women.
Hirao M; Hashimoto J; Ando W; Ono T; Yoshikawa H
J Bone Miner Metab; 2008; 26(3):260-4. PubMed ID: 18470667
[TBL] [Abstract][Full Text] [Related]
30. Postmenopausal osteoporosis. What have we learned since the introduction of bisphosphonates?
Chaiamnuay S; Saag KG
Rev Endocr Metab Disord; 2006 Jun; 7(1-2):101-12. PubMed ID: 17043761
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of vitamin K2 in the prevention and treatment of postmenopausal osteoporosis: A systematic review and meta-analysis of randomized controlled trials.
Ma ML; Ma ZJ; He YL; Sun H; Yang B; Ruan BJ; Zhan WD; Li SX; Dong H; Wang YX
Front Public Health; 2022; 10():979649. PubMed ID: 36033779
[TBL] [Abstract][Full Text] [Related]
32. [Large clinical trials for osteoporosis].
Meunier PJ
Therapie; 2003; 58(5):415-20. PubMed ID: 14682189
[TBL] [Abstract][Full Text] [Related]
33. Hip fracture protection by alendronate treatment in postmenopausal women with osteoporosis: a review of the literature.
Iwamoto J; Sato Y; Takeda T; Matsumoto H
Clin Interv Aging; 2008; 3(3):483-9. PubMed ID: 18982918
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of vitamin K2 for postmenopausal women with osteoporosis at a long-term follow-up: meta-analysis and systematic review.
Zhou M; Han S; Zhang W; Wu D
J Bone Miner Metab; 2022 Sep; 40(5):763-772. PubMed ID: 35711002
[TBL] [Abstract][Full Text] [Related]
35. [Guidelines for drug therapy of postmenopausal osteoporosis].
Dimai HP; Pietschmann P; Resch H; Leb G; Klaushofer K
Wien Med Wochenschr; 2002; 152(23-24):596-612. PubMed ID: 12530170
[TBL] [Abstract][Full Text] [Related]
36. Ranking antireabsorptive agents to prevent vertebral fractures in postmenopausal osteoporosis by mixed treatment comparison meta-analysis.
Migliore A; Broccoli S; Massafra U; Cassol M; Frediani B
Eur Rev Med Pharmacol Sci; 2013 Mar; 17(5):658-67. PubMed ID: 23543450
[TBL] [Abstract][Full Text] [Related]
37. Prevention and treatment of osteoporosis in women with breast cancer.
Mincey BA; Moraghan TJ; Perez EA
Mayo Clin Proc; 2000 Aug; 75(8):821-9. PubMed ID: 10943237
[TBL] [Abstract][Full Text] [Related]
38. Effects of vitamin K in postmenopausal women: mini review.
Guralp O; Erel CT
Maturitas; 2014 Mar; 77(3):294-9. PubMed ID: 24342502
[TBL] [Abstract][Full Text] [Related]
39. [Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium].
Uebelhart D; Frey D; Frey-Rindova P; Goerres G; Michel BA
Z Rheumatol; 2003 Dec; 62(6):512-7. PubMed ID: 14685711
[TBL] [Abstract][Full Text] [Related]
40. Treatment of osteoporosis with bisphosphonates.
Watts NB
Rheum Dis Clin North Am; 2001 Feb; 27(1):197-214. PubMed ID: 11285996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]